VuEssence

Website

VuEssence, Inc.

3 Investors
Molecular Diagnostics
ODESSA, FL

VuEssence, Inc. is a pioneering healthcare company that is focused on developing advanced molecular diagnostic devices for detecting stroke and other neurological injuries. By integrating innovative molecular analysis technologies, VuEssence aims to enhance the accuracy and efficiency of diagnosis and treatment in the medical field.

Products & Team

Advanced Molecular Diagnostic Devices

Medical DevicesSeed

These devices employ molecular analysis techniques to detect and manage stroke and neurological conditions, providing healthcare providers with rapid and precise diagnostic information.

Value Proposition

VuEssence's tools enable early detection and ongoing management of stroke and neurological injuries, which is vital for improving patient outcomes.

Pain Points

The need for more accurate and timely diagnostic tools to manage stroke and related neurological conditions effectively.

Genomic and transcriptomic analysis capabilitiesRapid diagnostic resultsActionable insights for healthcare providers
Industry
Biotechnology
Primary business sector
Founded
2025
Year established
Location
ODESSA, FL
Primary headquarters

Funding History

Total Raised:
$47.5K
E

Equity Offering

April 2025
$250.0K
Target
Progress
19%
Raised
$47.5K
Target
$250.0K
#000170940925000006